HR at 24 wk
MOTS-c Reconstitution Math MOTS-c - common doses at common vial sizes Vial Size 5 mg BAC Water 1.0 mL Concentration 5 mg/mL 5 mg Dose 1.0 mL (100 units) 2.5 mg Dose 0.50 mL (50 units) 1 mg Dose 0.20 mL (20 units) 200 mcg Dose 0.04 mL (4 units) Vial Size 5 mg BAC Water 2.0 mL Concentration 2.5 mg/mL 5 mg Dose 2.0 mL (200 units*) 2.5 mg Dose 1.0 mL (100 units) 1 mg Dose 0.40 mL (40 units) 200 mcg Dose 0.08 mL (8 units) Vial Size 10 mg BAC Water 1.0 mL Concentration 10 mg/mL 5 mg Dose 0.50 mL (50 units) 2.5 mg Dose 0.25 mL (25 units) 1 mg Dose 0.10 mL (10 units) 200 mcg Dose 0.02 mL (2 units) Vial Size 10 mg BAC Water 2.0 mL Concentration 5 mg/mL 5 mg Dose 1.0 mL (100 units) 2.5 mg Dose 0.50 mL (50 units) 1 mg Dose 0.20 mL (20 units) 200 mcg Dose 0.04 mL (4 units) Vial Size 10 mg BAC Water 3.0 mL Concentration 3.33 mg/mL 5 mg Dose 1.50 mL (150 units*) 2.5 mg Dose 0.75 mL (75 units) 1 mg Dose 0.30 mL (30 units) 200 mcg Dose 0.06 mL (6 units) * Volumes above 100 units exceed a standard 1 mL insulin syringe
A 2025 study published in Obesity found that semaglutide-induced weight loss improved mitochondrial oxidative phosphorylation efficiency in skeletal muscle in mice meaning GLP-1 medications may independently support some mitochondrial improvements through weight loss itself
It involves more than just diet and exercise
When that happens, fatigue, constipation, dizziness, hair shedding, nutrient gaps, and muscle loss risk may increase
They stimulate insulin secretion, inhibit glucagon release, and slow gastric emptying, potentially exerting protective effects on renal function 13
